In keeping with Vice President Biden’s Cancer Moonshot goal to expand patient access to new cancer therapies via clinical trials, the Association of American Cancer Institutes (AACI) looks forward to working with the National Cancer Institute (NCI) to increase awareness of NCI-supported clinical trials. We encourage AACI centers to explore novel tools, such as the new application programming interface available from the NCI, to help physicians and patients find information about NCI-supported clinical trials, moving us closer to our shared goal of maximizing patient opportunities to participate in clinical trials.
Read more here:
FACT SHEET: Vice President Biden Announces New Steps to Improve Clinical Trials Essential to Advancing the Cancer Moonshot (The White House)
We Are All Part of the Cancer Moonshot: Vice President Biden on Why Everyone’s Participation in Clinical Trials Matters (The official Medium account of the Vice President’s Cancer Moonshot)
Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer Moonshot (NCI Cancer Currents blog)
Dr. Ronald DePinho
In budget recommendations released March 4, President Barack Obama requested an increase of less than 1% ($970 million) for the National Institutes of Health (NIH); $200 million above Fiscal Year 2014, but a funding level below that of FY12. The proposal includes $4.931 billion for the National Cancer Institute (NCI), an increase of $7.5 million (0.2 percent) over FY14.
AACI greatly appreciates the president’s ongoing strong support for biomedical research and his willingness to increase NIH funding. However, his budget proposal falls far short of the inflation rate of 2.9 percent, a figure that NIH projected last year for the Biomedical Research and Development Price Index (BRDPI) for FY15.
AACI recommends a NIH budget of $32 billion for FY15 through the Labor-HHS Appropriations Subcommittees, nearly $2 billion more than the president’s proposal. A flat budget for NIH, and ultimately the NCI, will only slow innovation and discovery.
Speaking last month at a meeting of the AACI Government Relations Forum at the University of Texas MD Anderson Cancer Center, in Houston, center president Ronald DePinho, MD, underscored the need for increased federal funding for cancer research, noting that cancer incidence in the U.S. is projected to increase 45 percent between today and 2030.
“The major solutions for our patients will come from scientific innovations that will lead to transformation in cancer prevention, early detection and definitive cures,” Dr. DePinho said. “And our academic medical centers are the engines for such discoveries. It is critical that we vigorously support these national treasures to deal with the onslaught of people who will need cancer services.”